As shown in Table II, all of the top 10 genes that were up/downregulated in PC3-GFP cells following osteolytic tumor growth inhibition by OPG, were differentially expressed >3-fold, compared to control. The gene discussed is TNFRSF11B; the disease is neoplasm.